Ignite Creation Date:
2024-05-06 @ 4:25 PM
Last Modification Date:
2024-10-26 @ 2:10 PM
Study NCT ID:
NCT04984369
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-21
First Post:
2021-07-27
Brief Title:
The Efficacy of HLX208 BRAF V600E Inhibitor With Cetuximab for Metastatic Colorectal Cancer mCRC With BRAF V600E Mutation After First-line Treatment
Sponsor:
Organization:
Shanghai Henlius Biotech